{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:13:44Z","timestamp":1790716424437,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007337","name":"UFSM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007337","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"name":"FAPERGS\/CNPq (PRONEX)","award":["10\/0005-1"],"award-info":[{"award-number":["10\/0005-1"]}]},{"DOI":"10.13039\/501100004263","name":"FAPERGS","doi-asserted-by":"crossref","award":["10\/0711-6"],"award-info":[{"award-number":["10\/0711-6"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.neuropharm.2014.01.020","type":"journal-article","created":{"date-parts":[[2014,1,25]],"date-time":"2014-01-25T01:30:49Z","timestamp":1390613449000},"page":"580-589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Depression-related behavior and mechanical allodynia are blocked by 3-(4-fluorophenylselenyl)-2,5-diphenylselenophene in a mouse model of neuropathic pain induced by partial sciatic nerve ligation"],"prefix":"10.1016","volume":"79","author":[{"given":"Bibiana Mozzaquatro","family":"Gai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiani Folharini","family":"Bortolatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar Augusto","family":"Br\u00fcning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Angonesi","family":"Zborowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Luiz","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilson","family":"Zeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Wayne","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2014.01.020_bib1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/01.psy.0000204851.15499.fc","article-title":"Comorbid depression, chronic pain, and disability in primary care","volume":"68","author":"Arnow","year":"2006","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib2","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib3","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ejpain.2008.01.010","article-title":"Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice","volume":"12","author":"Benbouzid","year":"2008","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2014.01.020_bib4","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.biopsych.2005.11.003","article-title":"The role of CREB in depression and antidepressant treatment","volume":"59","author":"Blendy","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.01.020_bib5","first-page":"37","article-title":"Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain","volume":"26","author":"Blier","year":"2001","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(02)02428-7","article-title":"Anti-allodynic action of the tormentic acid, a triterpene isolated from plant, against neuropathic and inflammatory persistent pain in mice","volume":"453","author":"Bortalanza","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","article-title":"The mouse light\/dark box test","volume":"463","author":"Bourin","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0091-3057(01)00701-8","article-title":"Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents","volume":"71","author":"Brocco","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0304-3940(03)00009-0","article-title":"The effects of aging on thermal hyperalgesia and tactile-evoked allodynia using two models of peripheral mononeuropathy in the rat","volume":"339","author":"Crisp","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib10","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1213\/01.ane.0000204295.90178.77","article-title":"The impact of therapy on quality of life and mood in neuropathic pain: what is the effect of pain reduction?","volume":"102","author":"Deshpande","year":"2006","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pbb.2004.10.016","article-title":"Comparison of five different rat models of peripheral nerve injury","volume":"80","author":"Dowdall","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib12","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s10571-011-9782-2","article-title":"Intracerebroventricular 4-methylcatechol (4-MC) ameliorates chronic pain associated with depression-like behavior via induction of brain-derived neurotrophic factor (BDNF)","volume":"32","author":"Fukuhara","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib13","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1039\/C1OB06548C","article-title":"Synthesis and antidepressant-like activity of selenophenes obtained via iron(III)-PhSeSePh-mediated cyclization of Z-selenoenynes","volume":"10","author":"Gai","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neuropharm.2010.05.003","article-title":"Antidepressant-like pharmacological profile of 3-(4-fluorophenylselenyl)-2,5-diphenylselenophene: involvement of serotonergic system","volume":"59","author":"Gay","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.01.020_bib15","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1186\/1471-2458-11-770","article-title":"Pain as a global public health priority","volume":"11","author":"Goldberg","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.neuropharm.2014.01.020_bib16","first-page":"CD010292","article-title":"Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome","volume":"1","author":"Hauser","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib17","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.neubiorev.2009.10.011","article-title":"The mirror-image pain: an unclered phenomenon and its possible mechanism","volume":"34","author":"Huang","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.brainres.2011.01.002","article-title":"Role of different brain areas in peripheral nerve injury-induced neuropathic pain","volume":"1381","author":"Jaggi","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00213-010-1977-6","article-title":"Depression-like behavior and mechanical allodynia are reduced by bis selenide treatment in mice with chronic constriction injury: a comparison with fluoxetine, amitriptyline, and bupropion","volume":"212","author":"Jesse","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2014.01.020_bib20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0304-3959(98)00230-9","article-title":"Behavioural measures of depression and anxiety in rats with spinal nerve ligation-induced neuropathy","volume":"80","author":"Kontinen","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2014.01.020_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2012.08.015","article-title":"The genetics of selective serotonin reuptake inhibitors","volume":"136","author":"Kroeze","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib22","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1038\/sj.npp.1301590","article-title":"Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites","volume":"33","author":"Matsuzawa-Yanagida","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.01.020_bib23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.tips.2006.05.004","article-title":"Antidepressants and pain","volume":"27","author":"Mico","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib24","doi-asserted-by":"crossref","first-page":"10000","DOI":"10.1523\/JNEUROSCI.2507-05.2005","article-title":"Protease-activated receptor-1 and platelet-derived growth factor in spinal cord neurons are implicated in neuropathic pain after nerve injury","volume":"25","author":"Narita","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib25","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00204-011-0720-3","article-title":"Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds","volume":"85","author":"Nogueira","year":"2011","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0014-2999(79)90366-2","article-title":"Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity","volume":"57","author":"Porsolt","year":"1979","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pain.2008.05.003","article-title":"Anxiety-like behaviour in rats with mononeuropathy is reduced by the analgesic drugs morphine and gabapentin","volume":"139","author":"Roeska","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2014.01.020_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.brainres.2007.07.086","article-title":"Diphenyl diselenide attenuates acute thermal hyperalgesia and persistent inflammatory and neuropathic pain behavior in mice","volume":"1175","author":"Savegnago","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3959(90)91074-S","article-title":"A\u00a0novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury","volume":"43","author":"Seltzer","year":"1990","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2014.01.020_bib30","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1021\/ol802060f","article-title":"Copper iodide-catalyzed cyclization of (Z)-chalcogenoenynes","volume":"10","author":"Stein","year":"2008","journal-title":"Org. Lett."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2014.01.020_bib32","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1213\/01.ane.0000261514.19946.66","article-title":"Experimental neuropathy in mice is associated with delayed behavioral changes related to anxiety and depression","volume":"104","author":"Suzuki","year":"2007","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2014.01.020_bib34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/da.21951","article-title":"Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review","volume":"29","author":"Thaler","year":"2012","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.neuropharm.2014.01.020_bib35","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.biopsych.2011.07.017","article-title":"A\u00a0time-dependent history of mood disorders in a murine model of neuropathic pain","volume":"70","author":"Yalcin","year":"2011","journal-title":"Biol. Psychiatry"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814000276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814000276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T18:54:24Z","timestamp":1589223264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390814000276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":34,"alternative-id":["S0028390814000276"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.01.020","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depression-related behavior and mechanical allodynia are blocked by 3-(4-fluorophenylselenyl)-2,5-diphenylselenophene in a mouse model of neuropathic pain induced by partial sciatic nerve ligation","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}